Increased incidence of bronchopulmonary fistulas complicating pediatric pneumonia

A J McKee1, A Ives, I M Balfour-Lynn

  • 1Department of Paediatric Respiratory Medicine, Royal Brompton Hospital, Royal Brompton & Harefield NHS Foundation Trust, Sydney Street, London, UK.

Insights

Complicated pediatric pneumonia cases, including bronchopleural fistulas, significantly increased in 2008-2009. This rise was linked to Streptococcus pneumoniae serotype 3 infections, not covered by the then-current vaccine.

Area of Science:

  • Pediatric Infectious Diseases
  • Pulmonary Medicine
  • Microbiology

Background:

  • Complicated pneumococcal disease, including necrotizing pneumonia, has seen a rise.
  • An increase in pediatric empyema complicated by bronchopleural fistula and air leak was observed during 2008-2009.
  • The study aimed to identify potential causes for this observed increase.

Purpose of the Study:

  • To investigate the association between the increased incidence of bronchopleural fistulas in children with empyema and potential causative factors.
  • To compare the characteristics and outcomes of pediatric empyema cases with and without bronchopleural fistulas between two distinct time periods.

Main Methods:

  • Retrospective review of pediatric cases with parapneumonic effusion or empyema admitted between 2002-2007 and 2008-2009.
  • Comparison of the frequency of air leaks and bronchopleural fistulas between the two study periods.
  • Analysis of clinical outcomes, including hospital stay and surgical intervention rates, and identification of Streptococcus pneumoniae serotypes.

Main Results:

  • The frequency of air leaks/bronchopleural fistulas rose dramatically from 1% (2002-2007) to 33% (2008-2009) (P<0.0001).
  • Cases with bronchopleural fistulas showed significantly longer hospital stays (median 10 vs. 7 days) and higher surgical intervention rates (14% vs. 2%).
  • Streptococcus pneumoniae serotype 3 was identified in 91% of fistula cases versus 3% of non-fistula cases in the latter period.

Conclusions:

  • A marked increase in pediatric bronchopleural fistulas occurred in 2008-2009.
  • The rise in fistulas was associated with Streptococcus pneumoniae serotype 3 infections.
  • The role of serotype 3 prevalence changes in this increased incidence requires further investigation, especially considering the heptavalent pneumococcal vaccine's limitations at the time.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations: